Post-Market Surveillance With a Novel mHealth Platform

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

January 26, 2018

Primary Completion Date

December 25, 2018

Study Completion Date

December 25, 2018

Conditions
GastrectomyAtrial Fibrillation
Interventions
DEVICE

A mobile health platform

Patients pilot testing the smartphone based, mobile health platform called HUGO. Patients will also be given syncable devices to use that will provide additional insights into their health and health outcomes.Patients will be queried about specific symptoms related to their procedure at enrollment, one week post-procedure, at 4 weeks and again at 8 weeks.

Trial Locations (2)

55905

Mayo Clinic, Rochester

06510

Yale New Haven Hospital, New Haven

Sponsors
All Listed Sponsors
collaborator

Johnson & Johnson

INDUSTRY

collaborator

Food and Drug Administration (FDA)

FED

collaborator

Mayo Clinic

OTHER

lead

Yale University

OTHER